Effects of [ 123I]ADAM, a serotonin transporter radiopharmaceutical, on pregnant Sprague-Dawley rats

K. W. Chang, M. C. Lin, S. Y. Lee, H. Y. Chen, C. C. Chen, Y. K. Fu

Research output: Contribution to journalArticlepeer-review


Serotonin transport abnormalities are implicated in neuropsychiatric disorders. [ 123I]ADAM ([ 123I]-2-([2-({dimethylamino}methyl)phenyl]thio)-5-iodophenylamine) is a novel radiotracer that targets serotonin transporters. We assessed the toxicity of [ 123I]ADAM (18.5MBq) administered in early- and late-phases (8 and 14 day postfertilization, respectively) of pregnancy. The mortality, clinical status, and gross necropsy were measured in pregnant rats, and the fertility index was measured in rat offspring (weight, clinical observations). We found no dosing-related clinical signs. In conclusion, [ 123I]ADAM was not toxic in an animal pregnancy model.

Original languageEnglish
Pages (from-to)2646-2651
Number of pages6
JournalApplied Radiation and Isotopes
Issue number11
Publication statusPublished - Nov 1 2012
Externally publishedYes


  • ADAM
  • Animal pregnancy model
  • Depression
  • Toxicity

ASJC Scopus subject areas

  • Radiation


Dive into the research topics of 'Effects of [ <sup>123</sup>I]ADAM, a serotonin transporter radiopharmaceutical, on pregnant Sprague-Dawley rats'. Together they form a unique fingerprint.

Cite this